☰

Ugur Eskiocak - Publications

Affiliations: 
Associate Director, In Vivo Immunopharmacology Compass Therapeutics  
 2011-2016 Children's Research Institute University of Texas Southwestern Medical Center at Dallas, Dallas, TX, United States 
Tree Info Grants Similar researchers PubMed Report error

23 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Payne KK, Mine JA, Biswas S, Chaurio RA, Perales-Puchalt A, Anadon CM, Costich TL, Harro CM, Walrath J, Ming Q, Tcyganov E, Buras AL, Rigolizzo KE, Mandal G, Lajoie J, ... ... Eskiocak U, et al. BTN3A1 governs antitumor responses by coordinating αβ and γδ T cells. Science (New York, N.Y.). 369: 942-949. PMID 32820120 DOI: 10.1126/Science.Aay2767  0.336
2020 Gao X, Zhang Z, Mashimo T, Shen B, Nyagilo J, Wang H, Wang Y, Liu Z, Mulgaonkar A, Hu XL, Piccirillo SGM, Eskiocak U, Davé DP, Qin S, Yang Y, et al. Gliomas Interact with Non-glioma Brain Cells via Extracellular Vesicles. Cell Reports. 30: 2489-2500.e5. PMID 32101730 DOI: 10.1016/J.Celrep.2020.01.089  0.43
2019 Kasitinon SY, Eskiocak U, Martin M, Bezwada D, Khivansara V, Tasdogan A, Zhao Z, Mathews T, Aurora AB, Morrison SJ. TRPML1 Promotes Protein Homeostasis in Melanoma Cells by Negatively Regulating MAPK and mTORC1 Signaling. Cell Reports. 28: 2293-2305.e9. PMID 31461647 DOI: 10.1016/J.Celrep.2019.07.086  0.629
2019 Eskiocak U, Guzman W, Daly T, Nelson A, Bakhru P, Lajoie J, Haserlat S, Ottinger S, Liu L, Oliphant A, Leung A, Hemashettar G, Rennard R, Wolf B, Draghi M, et al. Abstract 3239: CTX-5861 mediated SIRPα blockade combines with tumor targeting antibodies, checkpoint blockade and/or CD137 agonism to elicit curative anti-tumor activity in syngeneic mouse models Cancer Research. 79: 3239-3239. DOI: 10.1158/1538-7445.Am2019-3239  0.339
2017 Eskiocak B, McMillan E, Mendiratta S, Kollipara R, Zhang H, Humphries C, Wang C, Garcia-Rodriguez J, Ding M, Zaman A, Rosales T, Eskiocak U, Smith MP, Sudderth J, Komurov K, et al. Biomarker Accessible and Chemically Addressable Mechanistic Subtypes of BRAF Melanoma. Cancer Discovery. PMID 28455392 DOI: 10.1158/2159-8290.Cd-16-0955  0.423
2017 Frankel AE, Eskiocak U, Gill JG, Yuan S, Ramesh V, Froehlich TW, Ahn C, Morrison SJ. Digoxin Plus Trametinib Therapy Achieves Disease Control in BRAF Wild-Type Metastatic Melanoma Patients. Neoplasia (New York, N.Y.). 19: 255-260. PMID 28278423 DOI: 10.1016/J.Neo.2017.01.010  0.56
2017 Potu H, Peterson LF, Kandarpa M, Pal A, Sun H, Durham A, Harms PW, Hollenhorst PC, Eskiocak U, Talpaz M, Donato NJ. Usp9x regulates Ets-1 ubiquitination and stability to control NRAS expression and tumorigenicity in melanoma. Nature Communications. 8: 14449. PMID 28198367 DOI: 10.1038/Ncomms14449  0.367
2016 Zhang L, Theodoropoulos PC, Eskiocak U, Wang W, Moon YA, Posner B, Williams NS, Wright WE, Kim SB, Nijhawan D, De Brabander JK, Shay JW. Selective targeting of mutant adenomatous polyposis coli (APC) in colorectal cancer. Science Translational Medicine. 8: 361ra140. PMID 27798265 DOI: 10.1126/Scitranslmed.Aaf8127  0.407
2016 Eskiocak U, Ramesh V, Gill JG, Zhao Z, Yuan SW, Wang M, Vandergriff T, Shackleton M, Quintana E, Frankel AE, Johnson TM, DeBerardinis RJ, Morrison SJ. Erratum: Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanoma. Nature Communications. 7: 13080. PMID 27681157 DOI: 10.1038/ncomms13080  0.678
2016 Eskiocak U, Ramesh V, Gill JG, Zhao Z, Yuan SW, Wang M, Vandergriff T, Shackleton M, Quintana E, Johnson TM, DeBerardinis RJ, Morrison SJ. Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanoma. Nature Communications. 7: 12336. PMID 27545456 DOI: 10.1038/Ncomms12336  0.71
2016 Frankel AE, Eskiocak U, Froehlich TW, Ahn C, Hoelscher AJ, Morrison S. Digoxin plus trametinib therapy of BRAF wild type metastatic melanoma patients. Journal of Clinical Oncology. 34: 9527-9527. DOI: 10.1200/Jco.2016.34.15_Suppl.9527  0.563
2015 Wang M, Eskiocak U, Agathokleous M, Yuan S, Crawley C, Morrison SJ. Therapeutic Synergy from Combined Inhibition of the SERCA Channel and MAPK Signaling Pathway in MAPK-Dependent Leukemia Blood. 126: 1264-1264. DOI: 10.1182/Blood.V126.23.1264.1264  0.605
2014 Ram RR, Mendiratta S, Bodemann BO, Torres MJ, Eskiocak U, White MA. RASSF1A inactivation unleashes a tumor suppressor/oncogene cascade with context-dependent consequences on cell cycle progression. Molecular and Cellular Biology. 34: 2350-8. PMID 24732797 DOI: 10.1128/Mcb.01506-13  0.397
2014 Zhang L, Kim SB, Eskiocak U, Posner B, Das P, Wright WE, De Brabander JK, Shay JW. Therapeutic targeting truncated adenomatous polyposis coli (APC) proteins for the selective killing of colorectal cancer cells Bmc Genomics. 15: O3. DOI: 10.1186/1471-2164-15-S2-O3  0.435
2014 Potu H, Pal A, Sun H, Peterson L, Talpaz M, Verhaegen M, Cao J, Eskiocak U, Morrison S, Donato NJ. Abstract 4435: Deubiquitinases Usp9x and Usp5 control tumorigenicity and apoptotic responsiveness in malignant melanoma Cancer Research. 74: 4435-4435. DOI: 10.1158/1538-7445.Am2014-4435  0.648
2012 Quintana E, Piskounova E, Shackleton M, Weinberg D, Eskiocak U, Fullen DR, Johnson TM, Morrison SJ. Human melanoma metastasis in NSG mice correlates with clinical outcome in patients. Science Translational Medicine. 4: 159ra149. PMID 23136044 DOI: 10.1126/Scitranslmed.3004599  0.596
2012 Ly P, Eskiocak U, Parker CR, Harris KJ, Wright WE, Shay JW. RNAi screening of the human colorectal cancer genome identifies multifunctional tumor suppressors regulating epithelial cell invasion. Cell Research. 22: 1605-8. PMID 23044803 DOI: 10.1038/Cr.2012.140  0.367
2011 Kim J, Eskiocak U, Stadler G, Lou Z, Kuro-o M, Shay JW, Wright WE. Short hairpin RNA screen indicates that Klotho beta/FGF19 protein overcomes stasis in human colonic epithelial cells. The Journal of Biological Chemistry. 286: 43294-300. PMID 22020932 DOI: 10.1074/Jbc.M111.267641  0.362
2011 Eskiocak U, Kim SB, Ly P, Roig AI, Biglione S, Komurov K, Cornelius C, Wright WE, White MA, Shay JW. Functional parsing of driver mutations in the colorectal cancer genome reveals numerous suppressors of anchorage-independent growth. Cancer Research. 71: 4359-65. PMID 21527559 DOI: 10.1158/0008-5472.Can-11-0794  0.338
2011 Ly P, Eskiocak U, Kim SB, Roig AI, Hight SK, Lulla DR, Zou YS, Batten K, Wright WE, Shay JW. Characterization of aneuploid populations with trisomy 7 and 20 derived from diploid human colonic epithelial cells. Neoplasia (New York, N.Y.). 13: 348-57. PMID 21472139 DOI: 10.1593/Neo.101580  0.367
2011 Eskiocak U, Kim SB, Ly P, Roig AI, Biglione S, Komurov K, Cornelius C, Wright WE, White MA, Shay JW. Abstract 2207: Functional interrogation of the colorectal cancer genome identifies numerous suppressors of anchorage-independent growth Cancer Research. 71: 2207-2207. DOI: 10.1158/1538-7445.Am2011-2207  0.363
2010 Eskiocak U, Kim SB, Roig AI, Kitten E, Batten K, Cornelius C, Zou YS, Wright WE, Shay JW. CDDO-Me protects against space radiation-induced transformation of human colon epithelial cells. Radiation Research. 174: 27-36. PMID 20681796 DOI: 10.1667/Rr2155.1  0.332
2010 Roig AI, Eskiocak U, Hight SK, Kim SB, Delgado O, Souza RF, Spechler SJ, Wright WE, Shay JW. Immortalized epithelial cells derived from human colon biopsies express stem cell markers and differentiate in vitro. Gastroenterology. 138: 1012-21.e1-5. PMID 19962984 DOI: 10.1053/J.Gastro.2009.11.052  0.38
Show low-probability matches.